Przedsiebiorstwo Wielobranzowe "Jumo" Sp. z o.o. (Poland)

Przedsiebiorstwo Wielobranzowe "Jumo" Sp. z o.o. is the corporate entity associated with the Grupa Mazovia healthcare platform, operating a multi-site network of specialized hospitals and outpatient services in Poland with a core focus on urology and minimally invasive surgical care. Primary business segments include hospital-based urological treatment (including oncourology), operative urology delivered through open, laparoscopic, endoscopic and robot-assisted procedures, and supporting outpatient consultation and diagnostics. The platform also provides gynecology and selected surgical services through hospital operations, supported by diagnostic capabilities and structured patient pathways spanning qualification, procedures, inpatient care and follow-up. A dedicated specialization is advanced robotic surgery utilizing da Vinci systems, integrated into complex urological treatment programs and positioned as a high-precision, minimally invasive approach. Additional segment capability includes URODYN, a specialized urology center focused on diagnostics and treatment of genitourinary disorders, including urodynamic diagnostics and management of urinary incontinence as well as broad urological consultation and cancer diagnostics for prostate, bladder, kidney and testicular conditions. The network further operates an advanced pathology laboratory (Zaklad Patomorfologii) built around digital pathology, end-to-end sample tracking and AI-supported diagnostic workflows, enabling telepathology collaboration and rapid oncological diagnostics at scale. Geographic scope is national, with key hospital assets in Warsaw (Ursynow), Czestochowa and Katowice, complemented by specialized centers and laboratory operations serving broader referral flows. Key assets include the hospital network, multiple operating theaters (including high-throughput surgical capacity in Katowice), da Vinci robotic systems, digitized diagnostic infrastructure, and ISO-aligned management standards. Strategic focus emphasizes specialization in urology and minimally invasive treatment, technology-led differentiation through robotic surgery and digital diagnostics, and network effects across sites to provide comprehensive care, scale diagnostic throughput and sustain clinical quality positioning in the Polish healthcare market.